89 related articles for article (PubMed ID: 14970586)
21. Signaling molecules in nonfamilial pulmonary hypertension.
Du L; Sullivan CC; Chu D; Cho AJ; Kido M; Wolf PL; Yuan JX; Deutsch R; Jamieson SW; Thistlethwaite PA
N Engl J Med; 2003 Feb; 348(6):500-9. PubMed ID: 12571257
[TBL] [Abstract][Full Text] [Related]
22. Co-transduction of lentiviral and adenoviral vectors for co-delivery of growth factor and shRNA genes in mesenchymal stem cells-based chondrogenic system.
Zhang F; Yao Y; Su K; Fang Y; Citra F; Wang DA
J Tissue Eng Regen Med; 2015 Sep; 9(9):1036-45. PubMed ID: 23193077
[TBL] [Abstract][Full Text] [Related]
23. Efficient adenoviral gene transfer to kidney cortical vasculature utilizing a fiber modified vector.
McDonald GA; Zhu G; Li Y; Kovesdi I; Wickham TJ; Sukhatme VP
J Gene Med; 1999; 1(2):103-10. PubMed ID: 10738574
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy.
March KL; Madison JE; Trapnell BC
Hum Gene Ther; 1995 Jan; 6(1):41-53. PubMed ID: 7703286
[TBL] [Abstract][Full Text] [Related]
25. Catheter-mediated pulmonary vascular gene transfer and expression.
Muller DW; Gordon D; San H; Yang Z; Pompili VJ; Nabel GJ; Nabel EG
Circ Res; 1994 Dec; 75(6):1039-49. PubMed ID: 7955142
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
Morrell NW
Proc Am Thorac Soc; 2006 Nov; 3(8):680-6. PubMed ID: 17065373
[TBL] [Abstract][Full Text] [Related]
27. Comparison between recombinant baculo- and adenoviral-vectors as transfer system in cardiovascular cells.
Grassi G; Köhn H; Dapas B; Farra R; Platz J; Engel S; Cjsareck S; Kandolf R; Teutsch C; Klima R; Triolo G; Kuhn A
Arch Virol; 2006 Feb; 151(2):255-71. PubMed ID: 16195789
[TBL] [Abstract][Full Text] [Related]
28. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
[TBL] [Abstract][Full Text] [Related]
29. BMPR2 gene therapy for PAH acts via Smad and non-Smad signalling.
Harper RL; Reynolds AM; Bonder CS; Reynolds PN
Respirology; 2016 May; 21(4):727-33. PubMed ID: 26809239
[TBL] [Abstract][Full Text] [Related]
30. Improved vascular gene transfer with a helper-dependent adenoviral vector.
Wen S; Graf S; Massey PG; Dichek DA
Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
[TBL] [Abstract][Full Text] [Related]
31. Adenoviral vector platform for transduction of constitutive and regulated tricistronic or triple-transcript transgene expression in mammalian cells and microtissues.
Gonzalez-Nicolini V; Sanchez-Bustamante CD; Hartenbach S; Fussenegger M
J Gene Med; 2006 Oct; 8(10):1208-22. PubMed ID: 16960915
[TBL] [Abstract][Full Text] [Related]
32. Formulation and in vitro and in vivo evaluation of a cationic emulsion as a vehicle for improving adenoviral gene transfer.
Kim SY; Lee SJ; Lim SJ
Int J Pharm; 2014 Nov; 475(1-2):49-59. PubMed ID: 25138255
[TBL] [Abstract][Full Text] [Related]
33. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
[TBL] [Abstract][Full Text] [Related]
34. Nacystelyn enhances adenoviral vector-mediated gene delivery to mouse airways.
Kushwah R; Oliver JR; Cao H; Hu J
Gene Ther; 2007 Aug; 14(16):1243-8. PubMed ID: 17525704
[TBL] [Abstract][Full Text] [Related]
35. Viruses in pharmaceutical research: pulmonary vascular disease.
Reynolds PN
Mol Pharm; 2011 Feb; 8(1):56-64. PubMed ID: 21138278
[TBL] [Abstract][Full Text] [Related]
36. Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications.
Chung IM; Ueno H; Pak YK; Kim JW; Choi DH; Shin GJ; Yang WI; Jang Ys
Exp Mol Med; 2002 Sep; 34(4):299-307. PubMed ID: 12515396
[TBL] [Abstract][Full Text] [Related]
37. In vivo adenovirus-mediated gene transfer to lungs via pulmonary artery.
Lemarchand P; Jones M; Danel C; Yamada I; Mastrangeli A; Crystal RG
J Appl Physiol (1985); 1994 Jun; 76(6):2840-5. PubMed ID: 7928919
[TBL] [Abstract][Full Text] [Related]
38. Systemic delivery of the interleukin-1 receptor antagonist protein using a new strategy of direct adenoviral-mediated gene transfer to skeletal muscle capillary endothelium in the isolated rat hindlimb.
Welling TH; Davidson BL; Zelenock JA; Stanley JC; Gordon D; Roessler BJ; Messina LM
Hum Gene Ther; 1996 Oct; 7(15):1795-802. PubMed ID: 8894671
[TBL] [Abstract][Full Text] [Related]
39. Targeting of high-capacity adenoviral vectors.
Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
[TBL] [Abstract][Full Text] [Related]
40. Optimization of adenoviral vector-mediated gene transfer to pulmonary arteries in newborn swine.
Badran S; Schachtner SK; Baldwin HS; Rome JJ
Hum Gene Ther; 2000 May; 11(8):1113-21. PubMed ID: 10834614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
